To celebrate Native American Heritage Month, we spoke with Karina Walters, Ph.D., M.S.W., Director of the NIH Tribal Research Health Office (THRO). Dr. Walters, an enrolled member of the Choctaw Nation of Oklahoma, shares what motivates her in working to improve the lives of Indigenous People, her vision for THRO and her own experience as a researcher.
The Investor Relations website contains information about Intellia Therapeutics’s business for stockholders, potential investors, and financial analysts.
Welcome! You are invited to join a meeting: Understanding Neuropathy. After registering, you will receive a confirmation email about joining the meeting.
Combinatorial immunotherapy may improve the efficacy of neoadjuvant checkpoint inhibitors in locoregionally advanced melanoma. In this issue of Cancer Cell, Davar and colleagues report a…
The EMA’s CHMP has issued a positive opinion regarding the use of amivantamab plus lazertinib in select patients with EGFR+ non–small cell lung cancer.
Hatim Husain, MD, discusses how the implementation of proactive prophylaxis strategies for patients taking amivantamab, including prophylactic antibiotics, good skin hygiene, and insights from the…
The FDA approved revumenib (Revuforj, Syndax), a menin inhibitor, for relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult…
An abstract is unavailable.
Developed to facilitate a better understanding across the prevention field of needed near-term next steps and long-term future directions to fully realize
Expert cancer information presented in plain language with visuals, charts, and definitions to empower patients and caregivers.
